ArticleBMC neurology2026
A novel STUB1 p.(Gln118*) nonsense variant in compound heterozygosity causes autosomal recessive spinocerebellar ataxia type 16 in a Chinese patient.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSpinocerebellar ataxias comprise a group of neurodegenerative disorders characterized by progressive cerebellar ataxia with clinical and genetic heterogeneity. Autosomal recessive spinocerebellar ataxia type 16 (SCAR16) is characterized by cerebellar ataxia accompanied by pyramidal tract damage, cognitive decline, hypogonadism, and extrapyramidal symptoms. SCAR16 is caused by mutations in the STIP1 homology and U-box containing protein 1 (STUB1) gene.
methodsThe whole-exome sequencing combined with long-range flanking polymerase chain reaction (PCR) were performed in a Chinese SCAR16 patient. Furthermore, we used quantitative real-time PCR and western blot analysis to investigate the function of variant in STUB1 in cultured cells.
resultsWe identified a compound heterozygote in STUB1 containing a novel nonsense variant, NM_005861.4:c.352 C > T, p.(Gln118*), and a pathogenic missense variant, NM_005861.4:c.433 A > C, p.(Lys145Gln), in a Chinese SCAR16 patient. The age at onset was 27 years old with clinical characteristics of cerebellar ataxia and increased tendon reflex. We found that STUB1 p.(Gln118*) variant generated truncated proteins of the C-terminus of Hsc70-interacting protein and caused the loss function of ubiquitin ligase activity.
conclusionsOur results confirmed the pathogenicity of the STUB1 p.(Gln118*) variant, expanding the spectrum of causative variants associated with SCAR16.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.